White Paper on Natural Products.

Abstract:

:The American College of Clinical Pharmacy (ACCP) published an initial white paper on herbal products in 2000. Since then, the global market for natural products has continued to expand, with tens of millions of consumers using such products on an annual basis in the United States alone. However, despite this expansion, natural products remain largely unregulated compared with prescription medications, have moderate- to low-level clinical evidence for efficacy, and continue to have safety concerns, including adulteration and misbranding. As comprehensive medication management experts, clinical pharmacists are uniquely qualified to navigate these concerns and advise patients appropriately. To develop and recommend a suitable care plan involving natural products, clinical pharmacists must establish a strong pharmacist-patient relationship, assess the appropriateness of therapy, educate the patient regarding key issues, and continuously monitor and follow up on the effectiveness of the care plan. This process should not only occur in an individual community or hospital setting, but also whenever a patient transitions from one care setting to another in cooperation with other clinicians.

journal_name

Pharmacotherapy

journal_title

Pharmacotherapy

authors

Gabay M,Smith JA,Chavez ML,Goldwire M,Walker S,Coon SA,Gosser R,Hume AL,Musselman M,Phillips J,Abe AM

doi

10.1002/phar.1874

subject

Has Abstract

pub_date

2017-01-01 00:00:00

pages

e1-e15

issue

1

eissn

0277-0008

issn

1875-9114

journal_volume

37

pub_type

杂志文章
  • Acetaminophen-related acute renal failure without fulminant liver failure.

    abstract:BACKGROUND:Our patient experienced acute renal failure but not fulminant hepatic failure from acetaminophen toxicity. OBJECTIVE:To review the clinical and laboratory characteristics of similar cases of acetaminophen nephrotoxicity. METHODS:A MEDLINE search and medical record search at two large teaching hospitals. R...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Eguia L,Materson BJ

    更新日期:1997-03-01 00:00:00

  • Antipsychotics, Delirium, and Acute Respiratory Distress Syndrome: What Is the Link?

    abstract::Acute respiratory distress syndrome (ARDS) is an acute inflammatory process that impairs the ability of the lungs to oxygenate and ultimately leads to respiratory failure. Patients who develop ARDS often have prolonged and complicated hospital courses putting them at risk for intensive care unit (ICU) delirium. Patien...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2093

    authors: Torbic H,Duggal A

    更新日期:2018-04-01 00:00:00

  • Acute care clinical pharmacy practice: unit- versus service-based models.

    abstract::This commentary from the 2010 Task Force on Acute Care Practice Model of the American College of Clinical Pharmacy was developed to compare and contrast the "unit-based" and "service-based" orientation of the clinical pharmacist within an acute care pharmacy practice model and to offer an informed opinion concerning w...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/PHAR.1042

    authors: American College of Clinical Pharmacy.,Haas CE,Eckel S,Arif S,Beringer PM,Blake EW,Lardieri AB,Lobo BL,Mercer JM,Moye P,Orlando PL,Wargo K

    更新日期:2012-02-01 00:00:00

  • Enoxaparin use in the neonatal intensive care unit: experience over 8 years.

    abstract:STUDY OBJECTIVE:To evaluate the effectiveness and safety of enoxaparin therapy in a neonatal intensive care unit (NICU). DESIGN:Retrospective chart review. SETTING:Level III NICU in a Canadian academic center. PATIENTS:All neonates treated with enoxaparin while in the NICU between January 1, 1998, and June 1, 2006. ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.27.9.1263

    authors: Malowany JI,Knoppert DC,Chan AK,Pepelassis D,Lee DS

    更新日期:2007-09-01 00:00:00

  • Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy.

    abstract:STUDY OBJECTIVES:To examine glycosylated hemoglobin (A1C) values longitudinally in patients who newly started metformin, sulfonylurea, or thiazolidinedione monotherapy; in a subset of patients whose A1C values were 7% or greater before starting therapy (baseline) and who achieved A1C goal (A1C < 7%) during therapy, rat...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.27.8.1102

    authors: Riedel AA,Heien H,Wogen J,Plauschinat CA

    更新日期:2007-08-01 00:00:00

  • Pilot study of a novel patient self-management program for warfarin therapy using venipuncture-acquired international normalized ratio monitoring.

    abstract:STUDY OBJECTIVE:To compare clinical and safety outcomes of warfarin therapy before and after implementation of a novel patient self-management (PSM) program in which patients received their venipuncture-derived international normalized ratio (INR) results through a secure online messaging system and adjusted their warf...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1139

    authors: Simmons BJ,Jenner KM,Delate T,Clark NP,Kurz D,Witt DM

    更新日期:2012-12-01 00:00:00

  • A retrospective review and assessment of benzodiazepines in the treatment of alcohol withdrawal in hospitalized patients.

    abstract::Little information has been published concerning differences among the benzodiazepines in treating hospitalized patients with severe symptoms of alcohol withdrawal. We attempted to determine the length and type of hospital stay, and the pattern and appropriateness of administration, dosage requirements, and costs asso...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Hoey LL,Nahum A,Vance-Bryan K

    更新日期:1994-09-01 00:00:00

  • Follow-up of adverse drug reactions from peginterferon alfa-2b-ribavirin therapy.

    abstract:STUDY OBJECTIVE:To investigate the adverse drug reactions (ADRs) from peginterferon alfa-2b plus ribavirin in patients infected with the hepatitis C virus (HCV). DESIGN:Prospective, observational, pharmacovigilance study. SETTING:Gastroenterology department of a French university hospital. PATIENTS:A cohort of conse...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.24.16.1546.50947

    authors: Bagheri H,Fouladi A,Barange K,Lapeyre-Mestre M,Payen JL,Montastruc JL,Vinel JP

    更新日期:2004-11-01 00:00:00

  • Pharmacokinetics of the Meropenem Component of Meropenem-Vaborbactam in the Treatment of KPC-Producing Klebsiella pneumoniae Bloodstream Infection in a Pediatric Patient.

    abstract::Meropenem-vaborbactam is a new β-lactam/β-lactamase inhibitor combination designed to target Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae. Meropenem-vaborbactam was United States Food and Drug Administration-approved for complicated urinary tract infections in patients 18 years of age or olde...

    journal_title:Pharmacotherapy

    pub_type:

    doi:10.1002/phar.2187

    authors: Hanretty AM,Kaur I,Evangelista AT,Moore WS 2nd,Enache A,Chopra A,Cies JJ

    更新日期:2018-12-01 00:00:00

  • Asian and Asian-American college students' awareness of osteoporosis.

    abstract:STUDY OBJECTIVE:To quantify Asian and Asian-American college students' knowledge of osteoporosis and preventive health behaviors. DESIGN:Sixty-four-question survey SETTING:University of Minnesota. SUBJECTS:One hundred sixty-eight male and female Asian and Asian-American students, mean age 21 +/- 3.4 years. MAIN RES...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.22.12.1047.33608

    authors: Nguyen DN,O'Connell MB

    更新日期:2002-08-01 00:00:00

  • Long-term effectiveness of enalapril plus extended-release diltiazem in essential hypertension.

    abstract:STUDY OBJECTIVE:To evaluate the efficacy and safety of a new combination product, enalapril-diltiazem ER, when administered over the long term. DESIGN:Open-label, titration to response, with treatment lasting 46 weeks after a 6-week, double-blind phase. SETTING:Medical clinics in the private and academic sectors. PA...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Applegate W,Cohen JD,Wolfson P,Davis A,Green S

    更新日期:1997-01-01 00:00:00

  • Association Between Time-in-Therapeutic Tacrolimus Range and Early Rejection After Heart Transplant.

    abstract:BACKGROUND:Historically, there is perceived pressure to achieve therapeutic levels of tacrolimus quickly after heart transplant (HT). We evaluated the association between time within therapeutic tacrolimus range and time to therapeutic trough and rejection in the 30 days following HT. METHODS:This is a single-center r...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.2262

    authors: Baker WL,Steiger S,Martin S,Patel N,Radojevic J,Darsaklis K,O'Bara L,Kutzler H,Dougherty J,Feingold A,Hammond J,Fusco D,Gluck JA

    更新日期:2019-05-01 00:00:00

  • Clinical and economic burden of opioid use for postsurgical pain: focus on ventilatory impairment and ileus.

    abstract::Opioid-related adverse drug events (ORADEs) can have a significant impact on patient recovery after surgery. This review investigates the impact of two ORADEs, respiratory depression and postoperative ileus (POI), on clinical and economic outcomes. Opioid-induced ventilatory impairment is a potentially serious ORADE t...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.2012.01178.x

    authors: Barletta JF

    更新日期:2012-09-01 00:00:00

  • Prolonged paralysis associated with long-term pancuronium use.

    abstract::We cared for a 4-year-old patient who had undergone orthotopic liver transplantation and was placed on a ventilator for respiratory distress associated with Pneumocystis carinii pneumonia. The neuromuscular blocking agent pancuronium bromide 1.0-1.2 mg every hour as needed was used to facilitate artificial ventilation...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/j.1875-9114.1989.tb04121.x

    authors: Haas JL,Shaefer MS,Miwa LJ,Wood RP,Shaw BW Jr

    更新日期:1989-01-01 00:00:00

  • Strength in Amalgamation: Newer Combination Agents for HIV and Implications for Practice.

    abstract::Antiretroviral (ART) therapy for the treatment of human immunodeficiency virus (HIV) infection has undergone significant changes over the past 30 years. Many single-tablet regimens (STRs), including newer fixed-dose combination (FDC) tablets, are available, offering patients several options for choosing a treatment re...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2055

    authors: McCoy C,Badowski M,Sherman E,Crutchley R,Smith E,Chastain DB,Society of Infectious Diseases Pharmacists.

    更新日期:2018-01-01 00:00:00

  • Therapy with macrolides in patients with cystic fibrosis.

    abstract::Cystic fibrosis affects 1/2500 individuals and is the most common lethal autosomal recessive disease in people of northern European descent. It is characterized by chronic infections with mucoid Pseudomonas aeruginosa and progressive deterioration of respiratory function. Much research has focused on the inflammatory ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.22.3.227.33544

    authors: Gaylor AS,Reilly JC

    更新日期:2002-02-01 00:00:00

  • Predictors of trough concentrations of oral ciprofloxacin.

    abstract::Patients enrolled in a fixed-dose clinical trial of oral ciprofloxacin had trough concentrations measured to document absorption and monitor compliance. The objective was to determine whether any demographic characteristics might be important predictors of the concentrations. Stepwise multivariate linear regression re...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:

    authors: Paladino JA,Forrest A,Wilton JH

    更新日期:1993-09-01 00:00:00

  • Incorporating Comprehensive Management of Direct Oral Anticoagulants into Anticoagulation Clinics.

    abstract::Anticoagulation clinics emerged as a means to optimize warfarin effectiveness and minimize bleeding risks. Anticoagulation clinics have traditionally been warfarin-based models due to the need for frequent blood-level monitoring, drug interactions, dietary considerations, and periprocedural management with warfarin. T...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1991

    authors: Mohammad I,Korkis B,Garwood CL

    更新日期:2017-10-01 00:00:00

  • Validity of cancer-related fatigue instruments.

    abstract::Fatigue is one of the most debilitating and common symptoms associated with hematologic and oncologic disorders and treatment strategies. Patient factors influence etiology and symptom manifestation, which in turn affect diagnosis, management, and monitoring. Fatigue instruments can assist with the identification, man...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.22.16.1433.33690

    authors: Schwartz AH

    更新日期:2002-11-01 00:00:00

  • Reduction in warfarin adverse events requiring patient hospitalization after implementation of a pharmacist-managed anticoagulation service.

    abstract:STUDY OBJECTIVE:To compare adverse events related to anticoagulation in patients assigned to a pharmacist-managed anticoagulation service versus those receiving usual care. DESIGN:Retrospective cohort analysis. SETTING:Three hundred-bed community hospital. PATIENTS:Four hundred twenty patients referred for anticoagu...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.25.5.685.63582

    authors: Locke C,Ravnan SL,Patel R,Uchizono JA

    更新日期:2005-05-01 00:00:00

  • Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns.

    abstract::Since the discovery of penicillin 80 years ago, gram-negative bacteria have become proficient at evading the lethal activity of β-lactam antibiotics, principally through the production of β-lactamases. The rapid emergence of penicillinases in both gram-positive and gram-negative bacteria led to the development of ceph...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.2012.01035.x

    authors: Rapp RP,Urban C

    更新日期:2012-05-01 00:00:00

  • Utilization of coagulation assays in clinical therapeutics.

    abstract::With the emergence of new anticoagulants, clinicians need a thorough understanding of coagulation assays. Various laboratory assays exist to measure the effectiveness of anticoagulants. Coagulation assays are the primary method for measuring the effectiveness of anticoagulants; therefore, a comprehensive understanding...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1283

    authors: Peters GL,Erwin PB,Pitlick MK,Stacy ZA

    更新日期:2013-11-01 00:00:00

  • 1995 National Clinical Pharmacy Services Study.

    abstract::To determine the extent of hospital-based clinical pharmacy services in 1995, we surveyed 1109 United States acute care, general, medical-surgical, and pediatric hospitals with 50 or more licensed beds. Fifteen clinical pharmacy services were assessed to determine pharmacists' specific patient care responsibilities. T...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Raehl CL,Bond CA,Pitterle ME

    更新日期:1998-03-01 00:00:00

  • Superwarfarin and glass ingestion with prolonged coagulopathy requiring high-dose vitamin K1 therapy.

    abstract::A 23-year-old man was brought to the emergency department after eating four boxes of brodifacoum-containing rodenticide over a 4-day interval and pieces from approximately two bottles of glass over the previous 2 weeks. He was asymptomatic but his prothrombin time was markedly elevated with an international normalized...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.23.10.1186.32755

    authors: Tsutaoka BT,Miller M,Fung SM,Patel MM,Olson KR

    更新日期:2003-09-01 00:00:00

  • Clinical and microbiologic analysis of a hospital's extended-spectrum beta-lactamase-producing isolates over a 2-year period.

    abstract:STUDY OBJECTIVE:To evaluate the microbiologic and clinical outcomes of patients with extended-spectrum beta-lactamase (ESBL)-producing isolates over a 2-year period. DESIGN:Retrospective analysis. SETTING:Tertiary care teaching hospital. PATIENTS:Twenty-one patients with cultures of confirmed ESBL-producing Escheric...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.23.12.1232.32706

    authors: Burgess DS,Hall RG 2nd,Lewis JS 2nd,Jorgensen JH,Patterson JE

    更新日期:2003-10-01 00:00:00

  • Omadacycline Enters the Ring: A New Antimicrobial Contender.

    abstract::Omadacycline is a novel aminomethylcycline approved for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections. This article reviews existing data pertaining to the biochemistry, mechanism of action, pharmacokinetics/pharmacodynamics, in vitro activity, and curre...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2185

    authors: Barber KE,Bell AM,Wingler MJB,Wagner JL,Stover KR

    更新日期:2018-12-01 00:00:00

  • Pharmacotherapy for idiopathic pulmonary arterial hypertension during the past 25 years.

    abstract:OBJECTIVE:To review the current pharmacotherapy for idiopathic pulmonary arterial hypertension (IPAH). METHODS:A search of the primary literature was conducted by using MEDLINE, the National Institutes of Health medical research Web site (www.clinicaltrials.gov), and the United States Food and Drug Administration's Ce...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.2006.26.1.68

    authors: Hackman AM,Lackner TE

    更新日期:2006-01-01 00:00:00

  • Alfuzosin treatment improves the rate and time for stone expulsion in patients with distal uretral stones: a prospective randomized controlled study.

    abstract:OBJECTIVE:To evaluate the safety and efficacy of alfuzosin treatment on rate and time of stone expulsion in patients with uncomplicated distal ureteral stones. PATIENTS AND METHODS:Prospective, randomized, open-label, controlled study. Patients > 18 years of age presenting to the outpatient urology clinic with uncompl...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/phar.1593

    authors: El Said NO,El Wakeel L,Kamal KM,Morad Ael R

    更新日期:2015-05-01 00:00:00

  • Rapid-Onset Thrombocytopenia Following Piperacillin-Tazobactam Reexposure.

    abstract::Drug-induced thrombocytopenia is a rare but serious adverse event that has been associated with multiple drugs including β-lactams. Although it mostly occurs with prolonged medication use, some cases of rapid-onset thrombocytopenia have been reported. We describe the case of a 69-year-old man who developed severe and ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1675

    authors: Nguyen VD,Tourigny JF,Roy R,Brouillette D

    更新日期:2015-12-01 00:00:00

  • Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia.

    abstract:STUDY OBJECTIVES:To compare the effectiveness of bivalirudin and argatroban in achieving anticoagulation goals and to compare clinical outcomes assessing the safety and efficacy in patients with known or suspected heparin-induced thrombocytopenia (HIT). DESIGN:Single-center, retrospective analysis. SETTING:Large tert...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.30.12.1229

    authors: Skrupky LP,Smith JR,Deal EN,Arnold H,Hollands JM,Martinez EJ,Micek ST

    更新日期:2010-12-01 00:00:00